FY 2021 Appropriations Provides FDA Healthy Boost – Plus More COVID-19 Funds
Budget authority increase for medical product safety is coupled with additional funds for coronavirus countermeasure development and advanced manufacturing.
You may also be interested in...
Amendment to require one-firth of the money be devoted to therapeutic review was defeated by the House Energy and Commerce Committee.
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.